Listen to the article

听取文章

3 min

3分钟

This audio is auto-generated. Please let us know if you have

此音频是自动生成的。如果您有任何问题，请告诉我们。

feedback

反馈

.

。

Dive Brief:

简报：

Eargo and Hearx

Eargo 和 Hearx

have merged

已经合并

to create the over-the-counter hearing aid company LXE Hearing, the companies said Monday.

周一，这些公司表示，将创立非处方助听器公司LXE Hearing。

Hearx, the maker of Lexie hearing aids, and Eargo competed for the OTC hearing aid market that the Food and Drug Administration created through

Lexie助听器的制造商Hearx与Eargo竞争食品药品监督管理局通过创建的非处方（OTC）助听器市场

the publication

出版物

of a final rule in 2022.

2022年最终规则的。

Patient Square Capital, which

患者广场资本，这家

took Eargo private

将Eargo私有化

in 2024, has invested $100 million in the combined company. LXE said the investment reflects confidence in the direct-to-patient hearing market.

2024年，已向合并后的公司投资了1亿美元。LXE表示，这项投资反映了对直接面向患者的助听器市场的信心。

Dive Insight:

深入洞察：

The option to buy hearing aids without a prescription

无需处方即可购买助听器的选择

attracted new entrants

吸引了新的进入者

to the market: Sony

面向市场：索尼

launched a device

启动了一个设备

;

；

HP

惠普

lent its name

借出了它的名字

to a product; Lexie

产品；Lexie

partnered with Bose

与Bose合作

;

；

and Eargo, which was

而且Eargo，这个公司

already selling

已经在售

products direct to consumers, faced increased competition. Apple also

产品直接面向消费者，面临竞争加剧。苹果公司也

entered the market

进入市场

last year.

去年。

Contending with the fallout of a Department of Justice investigation, Eargo’s

应对司法部调查的后果，Eargo的

gross systems shipped fell

总出货系统数量下降

from 45,136 in 2021 to 24,247 in 2022. The company

从 2021 年的 45,136 下降到 2022 年的 24,247。公司

reversed the trend

扭转了趋势

over the first nine months of 2023, shipping 18,613 devices compared to 15,384 over the comparable period of 2022, but still posted a $64.4 million net loss.

在 2023 年的前九个月，出货了 18,613 台设备，相比 2022 年同期的 15,384 台有所增长，但仍然录得 6,440 万美元的净亏损。

Patient Square, Eargo’s majority owner,

患者广场，Eargo的多数股东，

agreed to take

同意采取

the company private in October 2023. As a private company, Eargo

该公司于2023年10月私有化。作为一家私人公司，Eargo

has launched

已启动

two new OTC hearing aids, Eargo SE, which fits in the canal, and Link by Eargo

两款新的非处方助听器，Eargo SE，可放置在耳道内，以及Eargo的Link产品。

, which it called the first earbud-style, OTC hearing aid with Bluetooth 5.3.

，它被称为首款采用耳塞式设计、支持蓝牙5.3的非处方助听器。

Lexie

莱西

launched another product

推出了另一款产品

in its line of Bose-powered hearing aids in January 2024. Users can take an in-app hearing test to tailor the devices to their specific requirements. The test uses technology from Lexie’s parent company, Hearx, a provider of digital audiological equipment.

在2024年1月推出其Bose技术助听器系列。用户可以通过应用内的听力测试来根据自身特定需求定制设备。该测试采用Lexie母公司Hearx的技术，Hearx是一家数字听觉设备供应商。

Because Lexie and Eargo are private companies, there is little public information on how well their devices have performed commercially. The merger announcement quotes a report from industry data company Circana that found Lexie was the number one hearing aid brand in the U.S. from August 2023 to July 2024..

由于Lexie和Eargo是私人公司，关于其设备在商业上的表现，公开信息很少。合并公告引用了行业数据公司Circana的一份报告，该报告发现Lexie在2023年8月至2024年7月期间是美国排名第一的助听器品牌。

Hearx CEO and co-founder Nic Klopper will serve as CEO of the combined company. Eargo's interim CEO Bill Brownie will be COO.

赫尔克斯首席执行官兼联合创始人尼克·克洛珀将担任合并后公司的首席执行官。Eargo 的临时首席执行官比尔·布朗尼将担任首席运营官。

Seline

塞琳

Van der

范德

Wat

什么

and Brian Maguire of

和布莱恩·马奎尔

Hearx

听诊器

, and Tim Trine of

，以及蒂姆·特林

Eargo

Eargo

are also joining LXE’s C-suite.

也加入了LXE的高管团队。

Recommended Reading

推荐阅读

Apple wins FDA nod for hearing aid software for certain Airpods

苹果获得FDA批准，某些AirPods将配备助听器软件

By

通过

Nick Paul Taylor

尼克·保罗·泰勒

•

•

Sept. 13, 2024

2024年9月13日

purchase licensing rights

购买授权许可

Filed Under:

分类：

Digital Health,

数字健康，

Medical Devices,

医疗器械，

M&A

并购